These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 15318695)

  • 41. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea.
    Plummer S; Weaver MA; Harris JC; Dee P; Hunter J
    Int Microbiol; 2004 Mar; 7(1):59-62. PubMed ID: 15179608
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cleaning up Clostridium difficile infection.
    Wilcox MH
    Lancet; 1996 Sep; 348(9030):767-8. PubMed ID: 8813978
    [No Abstract]   [Full Text] [Related]  

  • 43. Clostridium difficile: familiar pathogen, changing epidemiology: a virulent strain has been appearing more often, even in patients not taking antibiotics.
    Todd B
    Am J Nurs; 2006 May; 106(5):33-6. PubMed ID: 16639241
    [No Abstract]   [Full Text] [Related]  

  • 44. Keeping watch over the Staphylococcus.
    Dancer SJ
    J Hosp Infect; 2008 Dec; 70(4):297. PubMed ID: 18952322
    [No Abstract]   [Full Text] [Related]  

  • 45. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea.
    Parkes GC; Sanderson JD; Whelan K
    Lancet Infect Dis; 2009 Apr; 9(4):237-44. PubMed ID: 19324296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clostridium-difficile-associated diarrhea].
    Bujanda L; Cosme A
    Gastroenterol Hepatol; 2009 Jan; 32(1):48-56. PubMed ID: 19174100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007.
    Weiss K; Boisvert A; Chagnon M; Duchesne C; Habash S; Lepage Y; Letourneau J; Raty J; Savoie M
    Infect Control Hosp Epidemiol; 2009 Feb; 30(2):156-62. PubMed ID: 19125681
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004.
    Weiss K; Bergeron L; Bernatchez H; Goyette M; Savoie M; Thirion D
    Int J Antimicrob Agents; 2007 Oct; 30(4):309-14. PubMed ID: 17644347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Established and potential risk factors for Clostridum difficile infection.
    Vaishnavi C
    Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [What is so difficult ... with C. difficile?].
    Dionne GD
    Perspect Infirm; 2005; 2(3):26-30. PubMed ID: 15686207
    [No Abstract]   [Full Text] [Related]  

  • 51. Clostridium difficile: improving the prevention paradigm in healthcare settings.
    Vassallo A; Tran MC; Goldstein EJ
    Expert Rev Anti Infect Ther; 2014 Sep; 12(9):1087-102. PubMed ID: 25109301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals.
    Miller MA; Hyland M; Ofner-Agostini M; Gourdeau M; Ishak M;
    Infect Control Hosp Epidemiol; 2002 Mar; 23(3):137-40. PubMed ID: 11918118
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Epidemiology, risk factors and prevention of Clostridium difficile nosocomial infections].
    Barbut F; Petit JC
    Pathol Biol (Paris); 2000 Oct; 48(8):745-55. PubMed ID: 11244603
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study on clostridium difficile-associated diarrhea suspected as nosocomial infection in urology ward].
    Ishida K; Yuhara K; Kanimoto Y; Ishihara S; Deguchi T
    Hinyokika Kiyo; 2005 May; 51(5):305-8. PubMed ID: 15977595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nosocomial diarrhoea due to Clostridium difficile.
    Riley TV
    Curr Opin Infect Dis; 2004 Aug; 17(4):323-7. PubMed ID: 15241076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence of Clostridium difficile associated diarrhoea in a tertiary care hospital.
    Kaneria MV; Paul S
    J Assoc Physicians India; 2012 Nov; 60():26-8. PubMed ID: 23767199
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical impact and associated costs of Clostridium difficile-associated disease.
    Spencer RC
    J Antimicrob Chemother; 1998 May; 41 Suppl C():5-12. PubMed ID: 9630369
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recognizing and managing Clostridium difficile-associated diarrhea.
    Miller JM; Walton JC; Tordecilla LL
    Medsurg Nurs; 1998 Dec; 7(6):348-9, 352-6. PubMed ID: 10036439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presumably hospital-transmitted Clostridium difficile infections based on epidemiological linkage.
    Kohler P; Bregenzer-Witteck A; Rafeiner P; Schlegel M
    Swiss Med Wkly; 2013; 143():w13824. PubMed ID: 23888435
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clostridium difficile-associated diarrhoea.
    Elliott B; Chang BJ; Golledge CL; Riley TV
    Intern Med J; 2007 Aug; 37(8):561-8. PubMed ID: 17640189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.